Delivery Order SPE2DB20D3303-SPE2DB25FA3PX
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $7.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,070.91 to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 mg tablets in quantities of 30, with an ultimate completion date of August 29, 2025. This firm fixed price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is listed...
- The Defense Logistics Agency awarded a delivery order valued at $5,053.83 to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, competitively awarded delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle with DLA. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,198.50 to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 mg tablets (30-count units). This firm fixed price, non-set-aside delivery order was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. XELJANZ XR is a prescription immunosuppressant medication used to treat rheumatoid arthritis...
- The Defense Logistics Agency awarded a delivery order valued at $5,451.63 to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-unit packages) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. XELJANZ XR is a prescription medication used to treat rheumatoid arthritis and other...
- The Defense Logistics Agency awarded a delivery order valued at $2,864.37 to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract calls for delivery to be completed by August 1, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. XELJANZ XR is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This firm fixed-price, competitively awarded delivery order carries a ceiling value of $21,837.17 with an ultimate completion date of September 11, 2025. The contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. XELJANZ XR is a...
- The Defense Logistics Agency awarded a delivery order valued at $3,565.45 to AmerisourceBergen Drug Corp for XELJANZ XR 11 MG tablets (30-count units) on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. XELJANZ XR is a prescription medication used to treat inflammatory conditions, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units, with a contract value of $3,374.46. This is a firm fixed-price delivery order issued on September 2, 2025, with completion scheduled for September 3, 2025. The award carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $11,275.80, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation and is scheduled for completion by August 13, 2025. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $2,025.47 to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-count unit of use packaging) on August 28, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The product is a prescription medication used in the treatment of rheumatoid...